Ananda Pharma PLC Total Voting Rights
January 07 2025 - 5:34AM
RNS Regulatory News
RNS Number : 4368S
Ananda Pharma PLC
07 January 2025
07 January 2025
Ananda Pharma plc
("Ananda" or the "Company")
Total Voting Rights
In accordance with the Financial Conduct
Authority's Disclosure and Transparency Rules, Ananda announces
that the Company has 4,299,146,581 ordinary shares of 0.2p each in
issue ("Ordinary Shares"), each share carrying the right to one
vote.
This figure of 4,299,146,581 Ordinary Shares may be used by
shareholders in the Company as the denominator for the calculations
by which they will determine if they are required to notify their
interest in, or a change to their interest in, the share capital of
the Company under the FCA's Disclosure and Transparency
Rules.
-Ends-
The Directors of the Company accept
responsibility for the contents of this announcement.
|
InvestorHub
Engage with us directly at Ananda Pharma
Investor Hub
|
Sign up at https://investors.anandapharma.co.uk
|
|
ANANDA PHARMA
PLC
Chief
Executive Officer
Melissa Sturgess
Finance Director
Jeremy Sturgess-Smith
|
+44 (0)7463 686 497
ir@anandapharma.co.uk
|
|
SP ANGEL
CORPORATE FINANCE LLP
Corporate
Finance
Richard Morrison
Caroline Rowe
|
+44 (0)20 3470 0470
|
|
Corporate
Broking
Abigail Wayne
Rob Rees
|
|
|
Yellow Jersey
PR
Charles Goodwin
Zara McKinlay
|
+44 (0)20 3004 9512
|
About Ananda
Pharma plc
Ananda is an AQSE-listed life sciences company
focused on the research and clinical development of CBD-based
therapies for a range of complex inflammatory pain
conditions
For further information on the Company
visit https://www.anandapharma.co.uk/
or sign up at
https://investors.anandapharma.co.uk
https://investors.anandapharma.co.uk/link/Ky0jBr
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
NEXEAFFXEDDSEFA
Ananda Pharma (AQSE:ANA)
Historical Stock Chart
From Dec 2024 to Jan 2025
Ananda Pharma (AQSE:ANA)
Historical Stock Chart
From Jan 2024 to Jan 2025
